Gregory J. Flesher, Chief Executive Officer at Novus Therapeutics, Inc. (NVUS), bought 117,918 shares at $9.99 ($1.2M) on 2017-05-10, disclosed to the SEC on 2017-05-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.99 | 58,959 | $589K | 50.0% |
| 2 | $9.99 | 58,959 | $589K | 50.0% |
| Total | $9.99 avg | 117,918 | $1.2M | 100% |
| Filing → |